Suraksha Diagnostic Limited (NSE:SURAKSHA)

India · Delayed Price · Currency is INR

325.80

+20.65 (6.77%)

Aug 21, 2026, 3:29 PM IST

3.64% (1Y)

Market Cap	16.97B +3.6%
Revenue (ttm)	3.25B +23.3%
Net Income	357.98M +7.6%
EPS	6.88 +9.5%
Shares Out	52.08M
PE Ratio	47.36
Forward PE	42.31
Dividend	0.50 (0.15%)
Ex-Dividend Date	Sep 15, 2026

Volume	182,252
Open	309.00
Previous Close	305.15
Day's Range	305.00 - 329.00
52-Week Range	224.10 - 333.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1992

Employees 1,300

Stock Exchange National Stock Exchange of India

Ticker Symbol SURAKSHA

Full Company Profile

Financial Performance

In fiscal year 2026, Suraksha Diagnostic's revenue was 3.10 billion, an increase of 23.13% compared to the previous year's 2.52 billion. Earnings were 321.87 million, an increase of 1.14%.

Financial Statements